Vaccine maker Catalent eligible for $2M from state as part of $230M expansion
October 29, 2021 at 13:45 PM EDT
This is the latest expansion in Maryland for the New Jersey-based vaccine maker which acquired Paragon Gene Therapy in 2019.
Photography by Christophe Tomatis